112 related articles for article (PubMed ID: 26675333)
1. Human NUP98-IQCG fusion protein induces acute myelomonocytic leukemia in mice by dysregulating the Hox/Pbx3 pathway.
Pan MM; Zhang QY; Wang YY; Liu P; Ren RB; Huang JY; Chen LT; Xi XD; Chen Z; Chen SJ
Leukemia; 2016 Jul; 30(7):1590-3. PubMed ID: 26675333
[No Abstract] [Full Text] [Related]
2. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.
Nakamura T
Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755
[TBL] [Abstract][Full Text] [Related]
3. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
Hirose K; Abramovich C; Argiropoulos B; Humphries RK
Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
[TBL] [Abstract][Full Text] [Related]
4. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
5. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
[TBL] [Abstract][Full Text] [Related]
6. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
[TBL] [Abstract][Full Text] [Related]
7. Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the
Monlish DA; Bhatt ST; Duncavage EJ; Greenberg ZJ; Keller JL; Romine MP; Yang W; Aplan PD; Walter MJ; Schuettpelz LG
Blood; 2018 Mar; 131(9):1032-1035. PubMed ID: 29358180
[No Abstract] [Full Text] [Related]
8. Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.
Qin H; Malek S; Cowell JK; Ren M
Oncogene; 2016 Oct; 35(43):5686-5691. PubMed ID: 27065320
[TBL] [Abstract][Full Text] [Related]
9. Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions.
Yung E; Sekulovic S; Argiropoulos B; Lai CK; Leung M; Berg T; Vollett S; Chang VC; Wan A; Wong S; Humphries RK
Leuk Res; 2011 Apr; 35(4):545-50. PubMed ID: 21130494
[TBL] [Abstract][Full Text] [Related]
10. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
11. RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia.
Lim JH; Jang S; Park CJ; Cho YU; Lee JH; Lee KH; Lee JO; Shin JY; Kim JI; Huh J; Seo EJ
Cancer Genet; 2014; 207(1-2):40-5. PubMed ID: 24613277
[TBL] [Abstract][Full Text] [Related]
12. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.
Palmqvist L; Pineault N; Wasslavik C; Humphries RK
PLoS One; 2007 Aug; 2(8):e768. PubMed ID: 17712416
[TBL] [Abstract][Full Text] [Related]
13. Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.
Thorne RM; Milne TA
Haematologica; 2015 Jul; 100(7):850-3. PubMed ID: 26130510
[No Abstract] [Full Text] [Related]
14. Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells.
Eguchi-Ishimae M; Eguchi M; Ohyashiki K; Yamagata T; Mitani K
Int J Hematol; 2009 Mar; 89(2):253-256. PubMed ID: 19241117
[No Abstract] [Full Text] [Related]
15. The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.
Saw J; Curtis DJ; Hussey DJ; Dobrovic A; Aplan PD; Slape CI
Leuk Res; 2013 Dec; 37(12):1668-73. PubMed ID: 24090997
[TBL] [Abstract][Full Text] [Related]
16. Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98-HOXA11 fusion.
Mizoguchi Y; Fujita N; Taki T; Hayashi Y; Hamamoto K
Am J Hematol; 2009 May; 84(5):295-7. PubMed ID: 19338047
[TBL] [Abstract][Full Text] [Related]
17. A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation.
Pan Q; Zhu YJ; Gu BW; Cai X; Bai XT; Yun HY; Zhu J; Chen B; Weng L; Chen Z; Xue YQ; Chen SJ
Oncogene; 2008 May; 27(24):3414-23. PubMed ID: 18084320
[TBL] [Abstract][Full Text] [Related]
18. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.
Sarma NJ; Yaseen NR
J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451
[TBL] [Abstract][Full Text] [Related]
19. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
[TBL] [Abstract][Full Text] [Related]
20. NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation.
Noura M; Tomita S; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Cancer Med; 2024 Jul; 13(13):e7445. PubMed ID: 38940430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]